Vivoryon Therapeutics NV
F:05Y
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
Laramide Resources Ltd
F:L4RA
|
CA |
|
C
|
Collins Foods Ltd
F:6CF
|
AU |
|
T
|
Tonnellerie Francois Freres SA
OTC:FRFTF
|
FR |
|
Enovix Corp
NASDAQ:ENVX
|
US |
|
M
|
MS&AD Insurance Group Holdings Inc
XMUN:59M
|
JP |
|
MS&AD Insurance Group Holdings Inc
F:59M
|
JP |
|
F
|
Fomento de Construcciones y Contratas SA
DUS:FCC
|
ES |
|
Concurrent Technologies PLC
LSE:CNC
|
UK |
|
X
|
Xenon Pharmaceuticals Inc
SWB:XP0
|
CA |
|
E
|
Exploits Discovery Corp
F:634
|
CA |
|
Clear Channel Outdoor Holdings Inc
F:C7C1
|
US |
|
N
|
Nichirei Corp
DUS:NI3
|
JP |
|
S
|
SNP Schneider Neureither & Partner SE
XMUN:SHF
|
DE |
|
K
|
Keppel Corporation Ltd
XMUN:KEP1
|
SG |
|
T
|
Tempur Sealy International Inc
XBER:TPD
|
US |
|
Origin Materials Inc
F:5ER
|
US |
|
E
|
Evercore Inc
BMV:EVR
|
US |
|
Tecan Group AG
F:TEN
|
CH |
|
U
|
UBE Corp
OTC:UBEOF
|
JP |
|
Intercede Group PLC
F:LYD
|
UK |
|
Recce Pharmaceuticals Ltd
OTC:RECEF
|
AU |
|
CTBC Financial Holding Co Ltd
TWSE:2891
|
TW |
|
Deep Yellow Ltd
OTC:DYLLF
|
AU |
Bankruptcy Probability
Vivoryon Therapeutics NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Vivoryon Therapeutics NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
Vivoryon Therapeutics NV
AEX:VVY
|
37m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Vivoryon Therapeutics NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Vivoryon Therapeutics NV has total debt of 11k EUR. This includes both short-term (0 EUR) and long-term (11k EUR) debt.
You can find a full breakdown on its Balance Sheet.
